Literature DB >> 23022417

The docosanoid neuroprotectin D1 induces homeostatic regulation of neuroinflammation and cell survival.

N G Bazan1.   

Abstract

The onset of neurodegenerations and nervous system injury both trigger cell signaling perturbations that lead to damage of neuronal circuits and synapic connections, as well as protective signaling that aims to halt disease onset. Here we review recent findings that support the role of the docosanoid mediator neuroprotectin D1 (NPD1) as an early response or sentinel during the initial phase of nervous system damage. NPD1 is derived from docosahexaenoic acid that is selectively concentrated and retained in the nervous system. The protein misfolding triggers the biosynthesis of NPD1 which in turn downregulates pathways that lead to cell death and changes the outcome to cell survival. Proteotoxic stress as a result of protein misfolding is a widespread event in many neurodegenerative diseases. Therefore, mechanisms and mediators such as NPD1 that curtail consequences of these events are of interest as leads in the search for novel preventive and or therapeutic approaches.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23022417      PMCID: PMC3538114          DOI: 10.1016/j.plefa.2012.08.008

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  26 in total

Review 1.  Evolutionary aspects of diet: the omega-6/omega-3 ratio and the brain.

Authors:  Artemis P Simopoulos
Journal:  Mol Neurobiol       Date:  2011-01-29       Impact factor: 5.590

Review 2.  Dietary fatty acids and the aging brain.

Authors:  Greg M Cole; Qiu-Lan Ma; Sally A Frautschy
Journal:  Nutr Rev       Date:  2010-12       Impact factor: 7.110

Review 3.  Neural mechanisms of ageing and cognitive decline.

Authors:  Nicholas A Bishop; Tao Lu; Bruce A Yankner
Journal:  Nature       Date:  2010-03-25       Impact factor: 49.962

4.  Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases.

Authors:  Nicolas G Bazan; Miguel F Molina; William C Gordon
Journal:  Annu Rev Nutr       Date:  2011-08-21       Impact factor: 11.848

Review 5.  Omega-3 polyunsaturated fatty acids in Alzheimer's disease: key questions and partial answers.

Authors:  F Calon
Journal:  Curr Alzheimer Res       Date:  2011-08       Impact factor: 3.498

Review 6.  Neuroprotective and ameliorative actions of polyunsaturated fatty acids against neuronal diseases: beneficial effect of docosahexaenoic acid on cognitive decline in Alzheimer's disease.

Authors:  Michio Hashimoto; Shahdat Hossain
Journal:  J Pharmacol Sci       Date:  2011-05-21       Impact factor: 3.337

7.  Neuroprotectin D1 modulates the induction of pro-inflammatory signaling and promotes retinal pigment epithelial cell survival during oxidative stress.

Authors:  Jorgelina M Calandria; Nicolas G Bazan
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

8.  Deficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer's disease.

Authors:  Giuseppe Astarita; Kwang-Mook Jung; Nicole C Berchtold; Vinh Q Nguyen; Daniel L Gillen; Elizabeth Head; Carl W Cotman; Daniele Piomelli
Journal:  PLoS One       Date:  2010-09-08       Impact factor: 3.240

9.  Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARγ-mediated mechanisms in Alzheimer's disease models.

Authors:  Yuhai Zhao; Frederic Calon; Carl Julien; Jeremy W Winkler; Nicos A Petasis; Walter J Lukiw; Nicolas G Bazan
Journal:  PLoS One       Date:  2011-01-05       Impact factor: 3.240

Review 10.  Endogenous signaling by omega-3 docosahexaenoic acid-derived mediators sustains homeostatic synaptic and circuitry integrity.

Authors:  Nicolas G Bazan; Alberto E Musto; Eric J Knott
Journal:  Mol Neurobiol       Date:  2011-09-15       Impact factor: 5.590

View more
  18 in total

Review 1.  Diet, cognition, and Alzheimer's disease: food for thought.

Authors:  Ane Otaegui-Arrazola; Pilar Amiano; Ana Elbusto; Elena Urdaneta; Pablo Martínez-Lage
Journal:  Eur J Nutr       Date:  2013-07-27       Impact factor: 5.614

Review 2.  Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids.

Authors:  Milan Fiala; Gijs Kooij; Karen Wagner; Bruce Hammock; Matteo Pellegrini
Journal:  FASEB J       Date:  2017-04-18       Impact factor: 5.191

3.  Dietary omega-6 fatty acid lowering increases bioavailability of omega-3 polyunsaturated fatty acids in human plasma lipid pools.

Authors:  Ameer Y Taha; Yewon Cheon; Keturah F Faurot; Beth Macintosh; Sharon F Majchrzak-Hong; J Douglas Mann; Joseph R Hibbeln; Amit Ringel; Christopher E Ramsden
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2014-02-24       Impact factor: 4.006

4.  Pediatric oral formulation of dendrimer-N-acetyl-l-cysteine conjugates for the treatment of neuroinflammation.

Authors:  Venkata K Yellepeddi; Raziye Mohammadpour; Siva P Kambhampati; Casey Sayre; Manoj K Mishra; Rangaramanujam M Kannan; Hamidreza Ghandehari
Journal:  Int J Pharm       Date:  2018-04-20       Impact factor: 5.875

Review 5.  Docosahexaenoic acid (DHA): An essential nutrient and a nutraceutical for brain health and diseases.

Authors:  Grace Y Sun; Agnes Simonyi; Kevin L Fritsche; Dennis Y Chuang; Mark Hannink; Zezong Gu; C Michael Greenlief; Jeffrey K Yao; James C Lee; David Q Beversdorf
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2017-03-10       Impact factor: 3.015

6.  Human cerebrospinal fluid fatty acid levels differ between supernatant fluid and brain-derived nanoparticle fractions, and are altered in Alzheimer's disease.

Authors:  Alfred N Fonteh; Matthew Cipolla; Jiarong Chiang; Xianghong Arakaki; Michael G Harrington
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

Review 7.  Neuroinflammation as a Common Denominator of Complex Diseases (Cancer, Diabetes Type 2, and Neuropsychiatric Disorders).

Authors:  Serena Asslih; Odeya Damri; Galila Agam
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

8.  Omega-3 fatty acid-derived resolvins and protectins in inflammation resolution and leukocyte functions: targeting novel lipid mediator pathways in mitigation of acute kidney injury.

Authors:  Song Hong; Yan Lu
Journal:  Front Immunol       Date:  2013-01-30       Impact factor: 7.561

Review 9.  Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA.

Authors:  Simon C Dyall
Journal:  Front Aging Neurosci       Date:  2015-04-21       Impact factor: 5.750

10.  Brain docosahexaenoic acid [DHA] incorporation and blood flow are increased in chronic alcoholics: a positron emission tomography study corrected for cerebral atrophy.

Authors:  John C Umhau; Weiyin Zhou; Shantalaxmi Thada; James Demar; Nahed Hussein; Abesh K Bhattacharjee; Kaizong Ma; Sharon Majchrzak-Hong; Peter Herscovitch; Norman Salem; Abigail Urish; Joseph R Hibbeln; Stephen C Cunnane; Stanley I Rapoport; Jussi Hirvonen
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.